Antiobiotic approval moves forward despite fears about risks
The government is on track to approve a new antibiotic to treat a pneumonia-like disease in cattle, despite warnings from health groups and a majority of the agency's own expert advisers that the decision will be dangerous for people.
Full Story »
This topic is extremely important, as we must be ever mindful of the FDA officials' inability to resist temptations placed upon them by the pharmaceutical industry. Over 80% of the studies done on new drug safety are privately funded, placing extreme pressure on the FDA to produce "good" results--the results desired by the funder. The questions about the potential risks of these new drugs must be answered convincingly, and must show a high degree of safety, before the healthcare consumers can have sufficient confidence in them.